Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 22 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 8 Breast Neoplasms 6 Neurologic Manifestations 1 Neoplasms 1 Mouth Neoplasms 1 Medulloblastoma 1 Lymphoma, Follicular 1 Lymphedema 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Deglutition Disorders 1 Colorectal Neoplasms 1 Breast Cancer Lymphedema 1 Breast Cancer Female 1 Brain Neoplasms 1 Bipolar Disorder 1

Interventions

Irinotecan 11 Oxaliplatin 8 Cetuximab 7 Fluorouracil 6 Leucovorin 5 Bevacizumab 5 Standard of Care 4 S 1 (combination) 4 Capecitabine 4 trifluridine tipiracil drug combination 2 tislelizumab 2 apatinib 2 Propranolol 2 Preoperative Exercise 2 Panitumumab 2 Levoleucovorin 2 Folfox protocol 2 Etodolac 2 Endoscopic Mucosal Resection 2 Drug Therapy 2 Chemotherapy, Adjuvant 2 trebananib 1 regorafenib 1 envafolimab 1 Trifluridine 1 Thalidomide 1 Surveys and Questionnaires 1 Occult Blood 1 Neoadjuvant Therapy 1 Moxibustion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Colorectal Neoplasms × Exercise × Clear all

NCT02264496 2019-07-15

PEACOCS

Hull University Teaching Hospitals NHS Trust

Phase NA Completed

Gastrointestinal

Motor Activity, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡